Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New therapy aims to curb Self-Harm in addiction

NCT ID NCT05476601

Disease control Sponsor: Pakistan Institute of Living and Learning Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a culturally adapted therapy called CMAP Plus is practical and acceptable for people with substance use disorder who also self-harm. The therapy combines problem-solving skills with motivational interviewing and was delivered weekly for 12 weeks. The trial involved 80 participants across six cities in Pakistan and focused on recruitment and attendance rates, not on whether the therapy actually reduces self-harm.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Culturally adapted problem-solving therapy plus motivational interviewing (CMAP Plus)
What this could lead to
If successful, this could provide a practical, low-cost therapy to help people with substance use disorder reduce self-harm behaviors.
What could go wrong
This is a small feasibility study (80 participants) testing whether the approach is acceptable and practical, not whether it works. Results may not apply outside Pakistan.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Dec 2023

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 and above. * Individuals diagnosed with SUD on DSM-5 criteria of mental disorders. * Having episodes of self-harm in last three months defined as a deliberate act to harm one's own body including but not limited to self-cutting, self-biting, self-poisoning, self-scratching, self-burning, self-hitting, pulling hair etc. assessed by deliberate self-harm inventory. * Capable to give informed consent. * Those who have completed detoxification process. Exclusion Criteria: * Participants with DSM-5 criteria of mental disorder other than SUD; due to a general medical condition or dementia, delirium, schizophrenia, bipolar disorder, personality disorders, learning disability or any other condition to the extent that engagement in the intervention would not be possible, e.g. communication difficulties. * Unlikely to be available for outcome assessments (temporary residence).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Self harm are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Self-Injurious Behavior substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Self harm Substance-related disorders

Contacts and locations

Locations

  • Pakistan Recovery Oasis

    Lahore, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.